DK1492789T3 - Tropanderivater som CCR5-modulatorer - Google Patents

Tropanderivater som CCR5-modulatorer

Info

Publication number: DK1492789T3
Authority: DK; Denmark
Prior art keywords: tropane derivatives; ccr5 modulators; ccr5; modulators; tropane
Prior art date: 2002-04-08

Application number

DK03710080T

Other languages

Danish (da)

English (en)

Inventor

Patricia Ann Basford

Peter Thomas Stephenson

Stefan Colin John Taylor

Anthony Pfizer Global Rrc Wood

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-08

Filing date

2003-03-31

Publication date

2006-09-11

2002-04-08 Priority claimed from GBGB0208071.1A external-priority patent/GB0208071D0/en

2003-01-23 Priority claimed from GB0301575A external-priority patent/GB0301575D0/en

2003-03-31 Application filed by Pfizer filed Critical Pfizer

2006-09-11 Application granted granted Critical

2006-09-11 Publication of DK1492789T3 publication Critical patent/DK1492789T3/da

Links

102100035875 C-C chemokine receptor type 5 Human genes 0.000 title 1
101710149870 C-C chemokine receptor type 5 Proteins 0.000 title 1
150000003813 tropane derivatives Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
AIDS & HIV (AREA)
Child & Adolescent Psychology (AREA)

DK03710080T 2002-04-08 2003-03-31 Tropanderivater som CCR5-modulatorer DK1492789T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0208071.1A GB0208071D0 (en)	2002-04-08	2002-04-08	Tropane derivatives useful in therapy
GB0301575A GB0301575D0 (en)	2003-01-23	2003-01-23	Tropane derivatives useful in therapy

Publications (1)

Publication Number	Publication Date
DK1492789T3 true DK1492789T3 (da)	2006-09-11

Family

ID=28793308

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03710080T DK1492789T3 (da)	2002-04-08	2003-03-31	Tropanderivater som CCR5-modulatorer

Country Status (40)

Country	Link
EP (1)	EP1492789B1 (de)
JP (2)	JP3793200B2 (de)
KR (1)	KR100734685B1 (de)
CN (1)	CN1324025C (de)
AP (1)	AP1789A (de)
AR (1)	AR039383A1 (de)
AT (1)	ATE328882T1 (de)
AU (1)	AU2003214503B2 (de)
BR (1)	BR0309118A (de)
CA (1)	CA2481482C (de)
CR (1)	CR7514A (de)
CU (1)	CU23282A3 (de)
CY (1)	CY1106114T1 (de)
DE (1)	DE60305903T2 (de)
DK (1)	DK1492789T3 (de)
DO (1)	DOP2003000624A (de)
EA (1)	EA007590B1 (de)
ES (1)	ES2263960T3 (de)
GE (1)	GEP20074210B (de)
HN (1)	HN2003000114A (de)
HR (1)	HRP20040940A2 (de)
IL (1)	IL164261A0 (de)
IS (1)	IS2577B (de)
MA (1)	MA27190A1 (de)
MX (1)	MXPA04009220A (de)
MY (1)	MY134223A (de)
NI (1)	NI200300053A (de)
NO (1)	NO329674B1 (de)
NZ (1)	NZ535452A (de)
OA (1)	OA12798A (de)
PA (1)	PA8570801A1 (de)
PE (1)	PE20040082A1 (de)
PL (1)	PL372968A1 (de)
PT (1)	PT1492789E (de)
RS (1)	RS51550B (de)
SI (1)	SI1492789T1 (de)
TN (1)	TNSN04194A1 (de)
TW (1)	TWI280130B (de)
UY (1)	UY27752A1 (de)
WO (1)	WO2003084954A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA007590B1 (ru) *	2002-04-08	2006-12-29	Пфайзер Инк.	Производные тропана в качестве модуляторов ccr5
US6855724B2 (en)	2002-04-08	2005-02-15	Agouron Pharmaceuticals, Inc.	Tropane derivatives useful in therapy
CA2579609A1 (en)	2003-09-10	2005-03-17	Virochem Pharma Inc.	Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
GB0323236D0 (en) *	2003-10-03	2003-11-05	Pfizer Ltd	Chemical compounds
ES2295924T3 (es) *	2003-10-03	2008-04-16	Pfizer, Inc.	Derivados de tropano imidazopirina sustituidos con actividad antagonista de los receptores ccr5 para el tratamiento de vih y de la inflamacion.
TW200533348A (en)	2004-02-18	2005-10-16	Theravance Inc	Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8131026B2 (en)	2004-04-16	2012-03-06	Validity Sensors, Inc.	Method and apparatus for fingerprint image reconstruction
DE602005022900D1 (de)	2004-10-04	2010-09-23	Validity Sensors Inc	Fingerabdruckerfassende konstruktionen mit einem substrat
WO2006064340A2 (en) *	2004-12-13	2006-06-22	Pfizer Limited	Process for the preparation of n-acyl beta-aminoaldehydes
WO2008063600A2 (en) *	2006-11-17	2008-05-29	Concert Pharmaceuticals Inc.	Triazolyl tropane derivatives
MX2009011063A (es)	2007-04-13	2009-10-30	Dong Wha Pharm Co Ltd	Aspartato de acido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-dia za-espiro[3.4]oct-6-il)-4-oxo-1,4-dihidro-[1,8]naftiridin-3-carbo xilico, metodo para preparar el mismo y composicion farmaceutica antimicrobiana que comprende el mismo.
US7947710B2 (en)	2007-08-27	2011-05-24	Theravance, Inc.	Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
CN101712679B (zh) *	2008-10-08	2013-04-10	中国科学院上海药物研究所	一种酰胺类化合物、其药物组合物及其制备方法和用途
WO2011061243A1 (en) *	2009-11-21	2011-05-26	F. Hoffmann-La Roche Ag	Heterocyclic antiviral compounds
CN102822163B (zh)	2009-12-23	2016-01-20	艾恩伍德医药品股份有限公司	Crth2调节剂
MX2012011415A (es)	2010-04-02	2013-02-26	Phivco 1 Llc	Terapia de combinacion que comprende un antagonista de ccr5, un inhibidor de proteasa de vih-1, y un potenciador farmacocinetico.
US20130259830A1 (en)	2010-07-12	2013-10-03	Ironwood Pharmaceuticals, Inc.	Crth2 modulators
WO2012009137A1 (en)	2010-07-12	2012-01-19	Ironwood Pharmaceuticals, Inc.	Crth2 modulators
HUE047354T2 (hu)	2011-05-18	2020-04-28	Vertex Pharmaceuticals Europe Ltd	Ivacaftor deuterizált származékai
WO2013024022A1 (en)	2011-08-12	2013-02-21	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and pharmaceutical compositions for treatment of pulmonary hypertension
CN103159754A (zh) *	2011-12-19	2013-06-19	中国科学院上海药物研究所	一种氨基丙基取代托烷胺类化合物、其药物组合物及其制备方法和用途
JP6146990B2 (ja) *	2012-11-16	2017-06-14	コンサートファーマシューティカルズインコーポレイテッド	重水素化されたｃｆｔｒ増強物質
GB201321749D0 (en) *	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
GB201321748D0 (en) *	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
US10196384B2 (en)	2015-03-31	2019-02-05	Vertex Pharmaceuticals (Europe) Limited	Deuterated CFTR modulators
HK1258473A1 (zh)	2015-09-25	2019-11-15	Vertex Pharmaceuticals (Europe) Limited	氘代cftr增效剂
JP2017105824A (ja) *	2017-02-10	2017-06-15	コンサートファーマシューティカルズインコーポレイテッド	重水素化されたｃｆｔｒ増強物質
WO2019109021A1 (en)	2017-12-01	2019-06-06	Vertex Pharmaceuticals Incorporated	Processes for making modulators of cystic fibrosis transmembrane conductance regulator
EP3768256A4 (de)	2018-03-19	2021-11-24	Emory University	Pan-tropische eingangsinhibitoren
JP6654223B2 (ja) *	2018-08-13	2020-02-26	バーテックスファーマシューティカルズ（ヨーロッパ）リミテッド	重水素化されたｃｆｔｒ増強物質
US11629196B2 (en)	2020-04-27	2023-04-18	Incelldx, Inc.	Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20001420A1 (es) *	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
WO2001080106A1 (en) *	2000-04-19	2001-10-25	Satoshi Yamazaki	Advertising-tool distribution method and magnetic recorded medium for the software
EP1526134B1 (de) *	2000-05-26	2008-09-03	Pfizer Limited	Triazolyltropanderivate als ccr5-modulatoren
EA007590B1 (ru) *	2002-04-08	2006-12-29	Пфайзер Инк.	Производные тропана в качестве модуляторов ccr5

2003
- 2003-03-31 EA EA200401167A patent/EA007590B1/ru not_active IP Right Cessation
- 2003-03-31 AT AT03710080T patent/ATE328882T1/de active
- 2003-03-31 PL PL03372968A patent/PL372968A1/xx unknown
- 2003-03-31 ES ES03710080T patent/ES2263960T3/es not_active Expired - Lifetime
- 2003-03-31 HR HR20040940A patent/HRP20040940A2/hr not_active Application Discontinuation
- 2003-03-31 AP APAP/P/2004/003147A patent/AP1789A/en active
- 2003-03-31 WO PCT/IB2003/001220 patent/WO2003084954A1/en not_active Ceased
- 2003-03-31 OA OA1200400262A patent/OA12798A/en unknown
- 2003-03-31 BR BR0309118-0A patent/BR0309118A/pt not_active IP Right Cessation
- 2003-03-31 KR KR1020047016104A patent/KR100734685B1/ko not_active Expired - Fee Related
- 2003-03-31 GE GEAP8437A patent/GEP20074210B/en unknown
- 2003-03-31 NZ NZ535452A patent/NZ535452A/en not_active IP Right Cessation
- 2003-03-31 DE DE60305903T patent/DE60305903T2/de not_active Expired - Lifetime
- 2003-03-31 IL IL16426103A patent/IL164261A0/xx unknown
- 2003-03-31 MX MXPA04009220A patent/MXPA04009220A/es active IP Right Grant
- 2003-03-31 RS YUP-888/04A patent/RS51550B/sr unknown
- 2003-03-31 EP EP03710080A patent/EP1492789B1/de not_active Expired - Lifetime
- 2003-03-31 DK DK03710080T patent/DK1492789T3/da active
- 2003-03-31 AU AU2003214503A patent/AU2003214503B2/en not_active Ceased
- 2003-03-31 CA CA002481482A patent/CA2481482C/en not_active Expired - Lifetime
- 2003-03-31 SI SI200330319T patent/SI1492789T1/sl unknown
- 2003-03-31 CN CNB03807639XA patent/CN1324025C/zh not_active Expired - Fee Related
- 2003-03-31 PT PT03710080T patent/PT1492789E/pt unknown
- 2003-03-31 JP JP2003582151A patent/JP3793200B2/ja not_active Expired - Lifetime
- 2003-04-04 MY MYPI20031257A patent/MY134223A/en unknown
- 2003-04-04 NI NI200300053A patent/NI200300053A/es unknown
- 2003-04-04 DO DO2003000624A patent/DOP2003000624A/es unknown
- 2003-04-04 PE PE2003000346A patent/PE20040082A1/es not_active Application Discontinuation
- 2003-04-07 TW TW092107880A patent/TWI280130B/zh not_active IP Right Cessation
- 2003-04-07 UY UY27752A patent/UY27752A1/es unknown
- 2003-04-07 AR ARP030101205A patent/AR039383A1/es unknown
- 2003-04-07 HN HN2003000114A patent/HN2003000114A/es unknown
- 2003-04-08 PA PA20038570801A patent/PA8570801A1/es unknown
2004
- 2004-09-16 IS IS7453A patent/IS2577B/is unknown
- 2004-09-29 MA MA27883A patent/MA27190A1/fr unknown
- 2004-10-06 TN TNP2004000194A patent/TNSN04194A1/fr unknown
- 2004-10-07 CU CU20040219A patent/CU23282A3/es unknown
- 2004-10-07 CR CR7514A patent/CR7514A/es unknown
- 2004-10-26 NO NO20044615A patent/NO329674B1/no not_active IP Right Cessation
2006
- 2006-02-03 JP JP2006027537A patent/JP4571078B2/ja not_active Expired - Lifetime
- 2006-07-04 CY CY20061100919T patent/CY1106114T1/el unknown

Also Published As

Publication number	Publication date
JP2006182784A (ja)	2006-07-13
ES2263960T3 (es)	2006-12-16
AU2003214503B2 (en)	2008-08-07
DE60305903T2 (de)	2007-03-08
HN2003000114A (es)	2004-05-05
RS51550B (sr)	2011-06-30
AP2004003147A0 (en)	2004-09-30
NO20044615L (no)	2004-10-26
TWI280130B (en)	2007-05-01
EP1492789B1 (de)	2006-06-07
CY1106114T1 (el)	2011-06-08
SI1492789T1 (sl)	2006-10-31
PA8570801A1 (es)	2004-11-26
JP4571078B2 (ja)	2010-10-27
NZ535452A (en)	2006-11-30
NI200300053A (es)	2005-11-01
IS2577B (is)	2010-02-15
WO2003084954A1 (en)	2003-10-16
KR20040099420A (ko)	2004-11-26
MA27190A1 (fr)	2005-01-03
CN1646526A (zh)	2005-07-27
EP1492789A1 (de)	2005-01-05
TW200403242A (en)	2004-03-01
PE20040082A1 (es)	2004-03-20
UY27752A1 (es)	2003-11-28
CA2481482A1 (en)	2003-10-16
DOP2003000624A (es)	2003-10-15
AP1789A (en)	2007-10-05
MXPA04009220A (es)	2005-09-30
PL372968A1 (en)	2005-08-08
HRP20040940A2 (en)	2005-04-30
MY134223A (en)	2007-11-30
PT1492789E (pt)	2006-09-29
IS7453A (is)	2004-09-16
JP3793200B2 (ja)	2006-07-05
RS88804A (sr)	2006-12-15
EA200401167A1 (ru)	2005-04-28
CA2481482C (en)	2009-11-10
GEP20074210B (en)	2007-10-10
AR039383A1 (es)	2005-02-16
EA007590B1 (ru)	2006-12-29
OA12798A (en)	2006-07-10
AU2003214503A1 (en)	2003-10-20
CN1324025C (zh)	2007-07-04
KR100734685B1 (ko)	2007-07-02
NO329674B1 (no)	2010-11-29
CU23282A3 (es)	2008-06-30
CR7514A (es)	2004-11-08
BR0309118A (pt)	2005-02-01
HK1076102A1 (en)	2006-01-06
TNSN04194A1 (fr)	2007-03-12
DE60305903D1 (de)	2006-07-20
ATE328882T1 (de)	2006-06-15
IL164261A0 (en)	2005-12-18
JP2005532285A (ja)	2005-10-27

Publication	Publication Date	Title
NO20044615L (no)	2004-10-26	Tropanderivater som CCR5-modulatorer
DK1284974T3 (da)	2004-06-07	Triazolyltropanderivater som CCR5-modulatorer
NO20052739D0 (no)	2005-06-07	CCR5-antagonister som medikamenter
NO20050426L (no)	2005-03-29	Arylkarbonylderivater som terapeutiske midler
NO20044654L (no)	2004-10-28	Piperidinoylpiperidiner som 5-HTIF-agonister
AU2003253535A1 (en)	2004-03-11	N-4-piperidinyl compounds as ccr5 modulators
DK1397364T3 (da)	2007-11-26	Hidtil ukendte pyrrolderivater som farmaceutiske midler
NO20055680D0 (no)	2005-12-01	Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20055135D0 (no)	2005-11-02	Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
NO20041317L (no)	2004-06-29	Benzimidazolidinondenvater som muskarine midler
NO20023283D0 (no)	2002-07-05	Flammestopper
DK1611131T3 (da)	2011-01-17	Pyrazolopyridin-derivater
NO20013149L (no)	2001-08-23	Piperidiner som CCR5-modulatorer
DK1501826T3 (da)	2007-01-29	Substituerede indoler som alpha-1-agonister
DK1735286T3 (da)	2012-04-02	Tetrahydroindazoler som cannabinoidmodulatorer
DK1789041T3 (da)	2008-09-08	Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
DK1797042T3 (da)	2009-03-02	Indozolonderivater som 11B-HSD1-inhibitorer
NO20050665L (no)	2005-04-18	Pyrrolidonderivater som MAOE inhibitoere
DK1828167T3 (da)	2014-10-20	Acrylamidderivater som antibiotiske midler
ATE456558T1 (de)	2010-02-15	Gabanerge modulatoren
NO20044092L (no)	2004-09-27	Oftalmisk sammensetning som innbefatter ascomycin
NO20043794L (no)	2004-09-10	Benzensulfonamidderivater som antipsykotiske midler
DE602004014772D1 (de)	2008-08-14	Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors
DK1648882T3 (da)	2008-11-24	3-fluor-piperidiner som NMDA/NR2B-antagonister
DK1560828T3 (da)	2006-09-04	Imidazoquinolinderivater som adenosin-A3-receptorligander